Skip to main content
. 2022 Oct 27;10(4):244–254. doi: 10.14791/btrt.2022.0030

Table 3. Overall survival rates in intracranial anaplastic meningioma.

Variables No. of progression/no. of patients (%) Univariate analysis Multivariate analysis
Survival (month, mean±SE) p value (log-rank) HR 95% CI p value
Overall 25/48 (52.1) 56.90±16.75
Age 0.881
<57 yrs 12/20 (60) 50.73±31.31
≥57 yrs 13/28 (46.4) 56.9±15.59
Sex 0.055 1.377 0.615–3.084 0.437
Male 12/30 (46.7) 77.70
Female 13/18 (72.2) 32.93±4.71
Diagnosis type 0.049 0.523 0.125–2.182 0.374
Primary 13/28 (53.6) 81.27
Secondary 12/20 (60.0) 36±5.48
Location 0.146 2.214 0.909–5.394 0.080
Superficial 16/35 (51.4) 61.70±19.23
Deep or skull base 9/13 (69.2) 18.60±8.91
Tumor size 0.341
<4.5 cm 12/19 (63.2) 37.53±18.40
≥4.5 cm 13/29 (51.7) 77.70
Peritumoral edema 0.918
Mild 10/18 (61.1) 50.73±31.55
Moderate to severe 15/30 (53.3) 56.90±15.97
Tumor shape 0.602
Round 10/17 (64.7) 77.70
Mushroome 15/31 (51.6) 49.90±10.25
Preoperative ECOG 0.267
0 or 1 10/24 (45.8) 77.70
≥2 15/24 (66.7) 49.90±13.80
Extent of resection <0.001 2.296 0.926–5.693 0.073
GTR 14/36 (44.4) -
STR 11/12 (91.7) 28.90±11.29
Simpson grade 0.058
1 or 2 14/31 (51.6) 81.27
3 or 4 or 5 11/17 (64.7) 32.93±14.83
Adjuvant radiation <0.001 0.161 0.036–0.731 0.018
No 12/16 (75.0) 18.20±10.71
Yes 13/32 (46.9) 81.27

SE, standard error; HR, hazard ratio; 95% CI, 95% confidence interval; ECOG, Eastern Cooperative Oncology Group; GTR, gross total resection; STR, subtotal resection